Rapport Therapeutics, Inc. (RAPP)

NASDAQ: RAPP · Real-Time Price · USD

46.98

+1.49 (3.28%)

At close: Aug 10, 2026, 4:00 PM EDT

47.30

+0.32 (0.68%)

After-hours: Aug 10, 2026, 4:18 PM EDT

Rapport Therapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Operating Income	-153.52	-125.1	-83.06	-36.18
Net Income	-137.16	-111.48	-78.31	-34.79
Earnings Per Share	-3.04	-2.86	-3.78	-23.10
EPS Growth	-	-	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Investments	436.08	490.54	305.28	147.48
Total Debt	10.11	11.48	1.48	2.15
Net Cash (Debt)	425.97	479.06	303.8	145.33
Net Cash Growth	71.36%	57.69%	109.04%	-
Net Cash Per Share	9.49	12.30	14.65	96.52

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Operating Cash Flow	-96.68	-87.47	-64.83	-27.18
Capital Expenditures	-0.47	-0.62	-2.41	-1.64
Free Cash Flow	-97.15	-88.09	-67.23	-28.82
Free Cash Flow Growth	-	-	-	-

Selected indicators aren't available for this stock.